Your browser doesn't support javascript.
loading
Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients.
Jacquier, Alix; Lambert, Tiphaine; Delattre, Jean-François; Djouadou, Malika; Vérine, Jérôme; Dumont, Clément; Desgrandchamps, François; Carosella, Edgardo D; LeMaoult, Joel; Rouas-Freiss, Nathalie.
Afiliação
  • Jacquier A; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France.
  • Lambert T; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France; Department of Medical Oncology, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, France
  • Delattre JF; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France; Department of Medical Oncology, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, France
  • Djouadou M; Department of Urology, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Vérine J; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France; Department of Pathology, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, France.
  • Dumont C; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France; Department of Medical Oncology, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, France
  • Desgrandchamps F; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France; Department of Urology, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Carosella ED; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France.
  • LeMaoult J; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France.
  • Rouas-Freiss N; Hemato-Immunology Research Department, CEA/DRF/François Jacob Institut, Saint Louis Research Institute (IRSL), Saint Louis Hospital, Paris, France; U-976-HIPI Unit, Université de Paris, Paris, France. Electronic address: nathalie.rouas-freiss@cea.fr.
Cancer Lett ; 519: 105-116, 2021 10 28.
Article em En | MEDLINE | ID: mdl-34186161

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Linfócitos T Citotóxicos / Linfócitos T CD4-Positivos / Antígenos CD / Antígenos HLA-G / Receptor B1 de Leucócitos Semelhante a Imunoglobulina / Neoplasias Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Linfócitos T Citotóxicos / Linfócitos T CD4-Positivos / Antígenos CD / Antígenos HLA-G / Receptor B1 de Leucócitos Semelhante a Imunoglobulina / Neoplasias Renais Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article